The U.S. Food and Drug Administration (FDA) is encouraging scientists and drug developers to use an alpha-synuclein seed amplification assay…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
The brain weakens unused neural connections in the striatum, a region involved in motor control and decision-making, through a nitric…
Having acute kidney injury increases the risk of developing dementia, including Parkinson’s disease with dementia, according to a study…
GT-02287, an oral small molecule from Gain Therapeutics, was found to be safe and well tolerated in healthy volunteers.
This fall, the Tampa Jewish Community Centers (JCCs) and Federation will host a symposium that aims to empower people…
Carbon monoxide (CO), a gas present in cigarette smoke, given at low dose may help to prevent Parkinson’s disease…
Restoring the energy supply of nerve cells in the brain by activating a gene called PGK1 — which encodes…
Cycling was more effective than electrical muscle stimulation at improving cognitive function, according to a small study. The results have…
Taking levodopa before bedtime can reduce the number of times people with Parkinson’s disease wake up during sleep…
A clinical trial will use a noninvasive, ultrasound-based technology to better understand how Parkinson’s disease develops and progresses at…